Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Comprehensive Segmental Revision System(SRS)

K-Number: K223631 · 2023-07-12

Decision Date2023-07-12
Product CodeKWT
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Comprehensive Segmental Revision System(SRS) is a medical device manufactured by Biomet Orthopedics. It received FDA 510(k) clearance on 2023-07-12 under approval number K223631. The device is classified under product code KWT. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Comprehensive Segmental Revision System(SRS)?

Comprehensive Segmental Revision System(SRS) is a medical device that received FDA 510(k) clearance on 2023-07-12. It is manufactured by Biomet Orthopedics. The 510(k) number is K223631.

When was Comprehensive Segmental Revision System(SRS) approved by the FDA?

Comprehensive Segmental Revision System(SRS) received FDA 510(k) clearance on 2023-07-12, under approval number K223631.

What company makes Comprehensive Segmental Revision System(SRS)?

Comprehensive Segmental Revision System(SRS) is manufactured by Biomet Orthopedics.

What is the FDA product code for Comprehensive Segmental Revision System(SRS)?

The FDA product code for Comprehensive Segmental Revision System(SRS) is KWT.

Related Clinical Trials

Related PubMed Literature

Other Devices by Biomet Orthopedics

Related Devices (Code: KWT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.